{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:59:37Z","timestamp":1781272777897,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejpb.2017.11.011","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T15:01:00Z","timestamp":1511362860000},"page":"71-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bioequivalence of locally acting lozenges: Evaluation of critical in vivo parameters and first steps towards a bio-predictive in vitro test method"],"prefix":"10.1016","volume":"123","author":[{"given":"Katharina","family":"Tietz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina I.","family":"Gutknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.11.011_b0005","unstructured":"United States Pharmacopoeia and National Formulary USP 40 - NF 35. 2017: United States Pharmacopoeial Convention Inc.: Rockville, MD, 2017."},{"key":"10.1016\/j.ejpb.2017.11.011_b0010","unstructured":"PhEur, European Pharmacopoeia ninth ed., vol. 7. 2017: Council of Europe."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jdent.2004.10.009","article-title":"Health benefits of saliva: a review","volume":"33","author":"Dodds","year":"2005","journal-title":"J. Dent."},{"issue":"6","key":"10.1016\/j.ejpb.2017.11.011_b0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.archoralbio.2015.03.004","article-title":"The functions of human saliva: a review sponsored by the World Workshop on Oral Medicine VI","volume":"60","author":"Dawes","year":"2015","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2017.11.011_b0025","unstructured":"C. Dawes, Salivary clearance and its effect on oral health, in: M. Edgar, D. O'Mullane (Ed.), Saliva and oral health, Stephen Hancocks Ltd.: London, 2012 pp. 81\u201396."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0030","first-page":"253","article-title":"Rhythms in salivary flow rate and composition","volume":"2","author":"Dawes","year":"1974","journal-title":"Int. J. Chronobiol."},{"issue":"6","key":"10.1016\/j.ejpb.2017.11.011_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0003-9969(79)90005-0","article-title":"Circadian variations in flow-rate and composition of human stimulated sub-mandibular saliva","volume":"24","author":"Ferguson","year":"1979","journal-title":"Arch. Oral Biol."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1875-595X.2004.tb00270.x","article-title":"Preferences and saliva stimulation of eight different chewing gums","volume":"54","author":"Bots","year":"2004","journal-title":"Int. Dental J."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000260845","article-title":"Effect of sucrose as a gustatory stimulus on the flow-rates of parotid and whole saliva","volume":"19","author":"Lagerlof","year":"1985","journal-title":"Caries Res."},{"issue":"2","key":"10.1016\/j.ejpb.2017.11.011_b0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0031-9384(87)90211-3","article-title":"Salivary changes in solution pH \u2013 a source of individual differences in sour taste perception","volume":"40","author":"Christensen","year":"1987","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.ejpb.2017.11.011_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9969(99)00119-3","article-title":"The buffer capacity and buffer systems of human whole saliva measured without loss of CO2","volume":"45","author":"Bardow","year":"2000","journal-title":"Arch. Oral Biol."},{"issue":"8","key":"10.1016\/j.ejpb.2017.11.011_b0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.archoralbio.2004.02.007","article-title":"The effects of prolonged gum chewing on salivary flow rate and composition","volume":"49","author":"Dawes","year":"2004","journal-title":"Arch. Oral Biology"},{"issue":"1","key":"10.1016\/j.ejpb.2017.11.011_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9969(88)90089-1","article-title":"The effects of different foods and concentrations of citric-acid on the flow-rate of whole saliva in man","volume":"33","author":"Watanabe","year":"1988","journal-title":"Arch. Oral Biol."},{"issue":"1","key":"10.1016\/j.ejpb.2017.11.011_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0031-9384(02)00957-5","article-title":"The relation between saliva flow after different stimulations and the perception of flavor and texture attributes in custard desserts","volume":"78","author":"Engelen","year":"2003","journal-title":"Physiol. Behav."},{"issue":"5","key":"10.1016\/j.ejpb.2017.11.011_b0075","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/00220345840630050201","article-title":"The volume of saliva in the mouth before and after swallowing","volume":"63","author":"Lagerlof","year":"1984","journal-title":"J. Dental Res."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.archoralbio.2014.11.016","article-title":"Characteristics of the saliva flow rates of minor salivary glands in healthy people","volume":"60","author":"Wang","year":"2015","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejpb.2017.11.011_b0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2015.01.007","article-title":"Characterisation of human saliva as a platform for oral dissolution medium development","volume":"91","author":"Gittings","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2017.11.011_b0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1113\/jphysiol.1975.sp010811","article-title":"Circadian rhythms in the flow rate and composition of unstimulated and stimulated human submandibular saliva","volume":"244","author":"Dawes","year":"1975","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000261439","article-title":"Effects of 9 different chewing-gums and lozenges on salivary flow-rate and pH","volume":"26","author":"Dawes","year":"1992","journal-title":"Caries Res."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0031-9384(87)90355-6","article-title":"The effect of oral stimulation on human parotid salivary flow rate and alpha-amylase secretion","volume":"41","author":"Froehlich","year":"1987","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0031-9384(90)90131-M","article-title":"Mastication and its influence on human salivary flow and alpha-amylase secretion","volume":"47","author":"Mackie","year":"1990","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.ejpb.2017.11.011_b0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1067\/mpr.2001.113778","article-title":"A review of saliva: normal composition, flow, and function","volume":"85","author":"Humphrey","year":"2001","journal-title":"J. Prosthetic Dent."},{"issue":"1","key":"10.1016\/j.ejpb.2017.11.011_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0909-8836.2004.00105.x","article-title":"Chewing behavior and salivary secretion","volume":"112","author":"Gaviao","year":"2004","journal-title":"Eur. J. Oral Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2017.11.011_b0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-9969(93)90071-S","article-title":"Influence of age on the secretory rates of the human minor salivary-glands and whole saliva","volume":"38","author":"Shern","year":"1993","journal-title":"Arch. Oral Biol."},{"issue":"6","key":"10.1016\/j.ejpb.2017.11.011_b0125","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/00220345920710060201","article-title":"Comparison of whole saliva flow-rates and mucin concentrations in healthy caucasian young and aged adults","volume":"71","author":"Navazesh","year":"1992","journal-title":"J. Dental Res."},{"issue":"9","key":"10.1016\/j.ejpb.2017.11.011_b0130","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/00220345840630091001","article-title":"Whole-saliva secretion rates in old and young healthy-subjects","volume":"63","author":"Benaryeh","year":"1984","journal-title":"J. Dental Res."},{"issue":"9","key":"10.1016\/j.ejpb.2017.11.011_b0135","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/00220345850640091101","article-title":"Age-related salivary flow-rate changes in controls and patients with oral lichen planus","volume":"64","author":"Gandara","year":"1985","journal-title":"J. Dental Res."},{"key":"10.1016\/j.ejpb.2017.11.011_b0140","unstructured":"FDA, Guidance for Industry: SUPAC-IR: immediate release solid oral dosage forms, in Scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation. 1995, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville MD, USA."},{"key":"10.1016\/j.ejpb.2017.11.011_b0145","unstructured":"FDA, Guidance: oral extended (controlled) release dosage forms in vivo bioequivalence and in vitro dissolution testing, U.S. Food and Drug Administration, Office of Generic Drugs: Rockville MD, USA, 1997."},{"key":"10.1016\/j.ejpb.2017.11.011_b0150","unstructured":"FDA, Guidance for Industry: Extended release oral dosage forms: development, evaluation, and application of in vitro\/in vivo correlations, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville MD, USA, 1997."},{"key":"10.1016\/j.ejpb.2017.11.011_b0155","unstructured":"FDA, Guidance for Industry: Dissolution Testing Of Immediate Release Solid Oral Dosage Forms, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville MD, USA, 1997."},{"key":"10.1016\/j.ejpb.2017.11.011_b0160","unstructured":"FDA, Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products \u2014 General Considerations, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville MD, USA, 2003."},{"key":"10.1016\/j.ejpb.2017.11.011_b0165","unstructured":"FDA, FDA-Recommended Dissolution Methods Database, CDER, Ed. 2017."},{"key":"10.1016\/j.ejpb.2017.11.011_b0170","unstructured":"L. Hughes, Buccal Dissolution of Active Substances, US 7470545 B2. 2003, Google Patents."},{"issue":"2","key":"10.1016\/j.ejpb.2017.11.011_b0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5173(94)00406-U","article-title":"Design of a dissolution apparatus suitable for in-situ release study of triamcinolone acetonide from bioadhesive buccal tablets","volume":"121","author":"Mumtaz","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.11.011_b0180","unstructured":"N.G. Das, S.K. Das, M.S. Surapaneni, Dissolution testing of solid dosage forms intended to be administered in the oral cavity, US 7331251 B2. 2008, Google Patents."},{"issue":"3","key":"10.1016\/j.ejpb.2017.11.011_b0185","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1208\/s12249-009-9298-y","article-title":"The application of modified flow-through cell apparatus for the assessment of chlorhexidine dihydrochloride release from lozenges containing sorbitol","volume":"10","author":"Musial","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ejpb.2017.11.011_b0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1248\/bpb.16.172","article-title":"A novel fine granule system for masking bitter taste","volume":"16","author":"Shirai","year":"1993","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ejpb.2017.11.011_b0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/cpb.44.399","article-title":"Influence of heat treatment on dissolution and masking degree of bitter taste for a novel fine granule system","volume":"44","author":"Shirai","year":"1996","journal-title":"Chem. Pharm. Bull."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2017.11.011_b0200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2007.03.032","article-title":"A biorelevant system to investigate in vitro drug released from a naltrexone implant","volume":"340","author":"Iyer","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2017.11.011_b0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2003.10.040","article-title":"Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation","volume":"277","author":"Ikinci","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2017.11.011_b0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2012.03.050","article-title":"A biorelevant in vitro release\/permeation system for oral transmucosal dosage forms","volume":"430","author":"Delvadia","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2017.11.011_b0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1081\/DDC-43947","article-title":"Development and evaluation of fast-dissolving film of salbutamol sulphate","volume":"31","author":"Mashru","year":"2005","journal-title":"Drug Develop. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2017.11.011_b0220","unstructured":"German Drug Codex (DAC) & New German Formulary (NRF): Federal Union of German Associations of Pharmacists (ABDA), 2010."},{"issue":"1","key":"10.1016\/j.ejpb.2017.11.011_b0225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/ajplegacy.1954.178.1.155","article-title":"Excretion of sodium, potassium, chloride and carbon dioxide in human parotid saliva","volume":"178","author":"Thaysen","year":"1954","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.ejpb.2017.11.011_b0230","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/ajplegacy.1959.196.4.831","article-title":"Role of parotid ducts in secretion of hypotonic saliva","volume":"196","author":"Brusilow","year":"1959","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.ejpb.2017.11.011_b0235","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1601-0825.2005.01217.x","article-title":"The distribution of oral mucosal pH values in healthy saliva secretors","volume":"12","author":"Aframian","year":"2006","journal-title":"Oral Diseases"},{"issue":"4","key":"10.1016\/j.ejpb.2017.11.011_b0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000260684","article-title":"A mathematical model of salivary clearance of sugar from the oral cavity","volume":"17","author":"Dawes","year":"1983","journal-title":"Caries Res."},{"key":"10.1016\/j.ejpb.2017.11.011_b0245","unstructured":"United States Pharmacopoeia and National Formulary USP 23 - NF 18: United States Pharmacopoeial Convention Inc.: Rockville, MD, 2014."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117309980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117309980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T13:00:27Z","timestamp":1570366827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117309980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":49,"alternative-id":["S0939641117309980"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.11.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioequivalence of locally acting lozenges: Evaluation of critical in vivo parameters and first steps towards a bio-predictive in vitro test method","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}